Related Experiment Video
Updated: Apr 14, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Idiopathic pediatric chronic kidney disease: can genomic technology crack the case?
Insights
Genomic imbalances were found in many children with chronic kidney disease (CKD) of unknown causes. This genetic analysis identified unexpected causes of pediatric CKD, suggesting genome-wide evaluation for diagnosis.
Area of Science:
- Pediatric Nephrology
- Medical Genetics
Background:
- Most pediatric chronic kidney disease (CKD) cases lack a clear cause.
- Diagnosing structural abnormalities and glomerular injury in pediatric CKD is straightforward, but idiopathic cases are common.
Purpose of the Study:
- To investigate genomic variations in children with idiopathic CKD.
- To identify genetic underpinnings of pediatric CKD with unknown etiology.
Main Methods:
- Utilized chromosomal microarrays to assess genomic variation.
- Compared genomic data from children with idiopathic CKD to control individuals.
Main Results:
- A significant portion of children with idiopathic CKD exhibited identifiable genomic imbalances.
- Pathogenic genetic alterations, not clinically suspected, were identified in some cases through detailed analysis of these imbalances.
Conclusions:
- Genome-wide evaluation is supported for diagnosing pediatric CKD.
- Further research is needed to integrate this genomic approach into routine clinical practice for pediatric CKD.
Abstract:
In children, chronic kidney disease (CKD) that results from structural abnormalities and glomerular injury is readily diagnosed; however, most cases of pediatric CKD are of unknown etiology. In this issue of the JCI, Verbitsky and colleagues used chromosomal microarrays to evaluate genomic variation in children with CKD. Compared with control individuals, a substantial proportion of children with idiopathic CKD had clearly identifiable genomic imbalances. Moreover, in some cases, detailed analysis of these imbalances identified pathogenic alterations that were unsuspected based on clinical presentation. The results of this study support genome-wide evaluation for pediatric cases of CKD; however, more work will need to be done before such an approach is widely available in the clinic.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Pharmacogenomics: Identification of New Drug Targets
Nephrons

